Condition: Ovarian Cancer · Fallopian Tube Carcinoma · Ovarian Carcinoma · Sponsor: Memorial Sloan Kettering Cancer Center
Participants will be scheduled for primary cytoreductive surgery as part of their standard care. Before surgery, participants will be assigned by chance to a study group. Depending on which group they are in, they will receive either acute normovolemic hemodilution/ANH during surgery or standard surgical management during surgery. The researchers think acute normovolemic hemodilution/ANH may decrease the need for allogenic blood transfusion/ABT in people having primary cytoreductive surgery.
This description comes directly from the study's public registry record.
Dennis Chi, MD · 212-639-5016 · chid@mskcc.org
Ginger Gardner, MD · 212-639-2375 · gardnerg@mskcc.org
Always discuss trial participation with your own doctor first.
| Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (Limited protocol activities) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (Limited protocol activities) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (Limited protocol activities) | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center (All protocol activities) | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06290193